Thaum nws los txog rau kev noj qab haus huv hauv plab, muaj ntau yam tshuaj siv tau los kho cov mob sib txawv. Ib qho tshuaj zoo li no uas tau khaws kev txiav txim siab tom qab lub sijhawm ntev yogLinaclotide. Tab sis dab tsi yog qhov tseeb yog Linaclotide, thiab nws puas yog prostaglandin pab pawg?
Structure thiab Function Linaclotide ntawm cov tshuaj
Linaclotide yog ib tug engineered 14-amino corrosive peptide uas muaj qhov chaw rau cov tshuaj hu ua guanylate cyclase-C (GC-C) agonists. Nws yog tsim los kho inveterate clogging thiab phem tempered plob tsis so tswj nrog obstruction (IBS-C). Tsis zoo li ntau lwm cov kev daws teeb meem hauv plab hnyuv, Linaclotide muaj cov qauv tshwj xeeb thiab cov khoom ntawm kev ua haujlwm uas ua rau nws sib nrug.
Cov qauv peptide ntawm Linaclotide tau piav qhia los ua kom pom kev ua haujlwm ntawm cov tshuaj hormones tshwm sim hauv txoj hnyuv, tshwj xeeb yog guanylin thiab uroguanylin. Cov tshuaj hormones no ua lub luag haujlwm tseem ceeb hauv kev tswj cov kua dej tawm thiab kev txav mus rau sab hauv. Los ntawm kev tsom xam cov tshuaj hormones, Linaclotide tuaj yeem ua kom muaj zog ntawm GC-C receptors pom nyob rau ntawm lub luminal nto ntawm plab hnyuv epithelial hlwb.
Thaum twgLinaclotideKev sib raug zoo rau GC-C receptors, nws ua rau muaj kev cuam tshuam ntawm lub sijhawm uas nws thiaj li ua rau nthuav tawm cov kua tawm mus rau hauv txoj hnyuv lumen thiab ua rau lub plab zom mov sai. Cov cuab yeej no ua rau muaj qhov sib txawv yooj yim nres thiab cuam tshuam txog kev mob tshwm sim, muab kev pab rau cov neeg mob uas muaj kev cuam tshuam tsis tu ncua los yog IBS-C.
 |
 |
 |
Linaclotide vs. Prostaglandin Derivatives: Ib qho piv txwv
Txhawm rau teb cov lus nug hauv lub npe: Tsis yog, Linaclotide tsis yog prostaglandin derivative. Txawm hais tias ob qho tib si Linaclotide thiab prostaglandin derivatives tuaj yeem cuam tshuam rau lub plab zom mov, lawv txawv txawv hauv lawv cov qauv, keeb kwm, thiab cov txheej txheem ntawm kev ua.
Prostaglandins yog ib pawg ntawm physiologically active lipid tebchaw uas yog muab los ntawm arachidonic acid. Lawv raug tsim nyob rau hauv lub cev thiab ua si ntau lub luag hauj lwm nyob rau hauv o, mob, kub taub hau, thiab kev tswj ntawm du nqaij contraction. Prostaglandin derivatives, raws li lub npe qhia, yog cov khoom siv hluavtaws uas zoo ib yam li ntuj prostaglandins thiab feem ntau ua raws li lawv cov teebmeem.
Nyob rau hauv sib piv, Linaclotide yog ib tug hluavtaws peptide uas tsis yog muab los ntawm los yog structurally muaj feem xyuam rau prostaglandins. Nws cov txheej txheem ntawm kev ua haujlwm yog tshwj xeeb rau GC-C receptors, uas txawv ntawm prostaglandins feem ntau ua haujlwm li cas. Txawm hais tias qee qhov prostaglandins tuaj yeem cuam tshuam rau lub plab zom mov thiab tso zis, lawv ua li ntawd los ntawm txoj kev sib txawv, feem ntau cuam tshuam nrog cov leeg nqaij leeg lossis so.
Nov yog qee qhov sib txawv tseem ceeb ntawmLinaclotidethiab prostaglandin derivatives:
- Qauv:Linaclotide yog peptide, thaum prostaglandin derivatives yog lipid-based molecules.
- Keeb kwm:Linaclotide yog cov hluavtaws tag nrho, thaum prostaglandin derivatives yog raws li cov khoom sib xyaw ua ke.
- Mechanism ntawm Action:Linaclotide ua haujlwm tshwj xeeb ntawm GC-C receptors, thaum prostaglandin derivatives muaj ntau yam teebmeem thoob plaws hauv lub cev.
- Qhov tshwj xeeb:Linaclotide yog qhov tshwj xeeb heev rau nws lub hom phiaj receptors hauv plab, thaum prostaglandin derivatives tuaj yeem muaj kev cuam tshuam ntau dua.
- Cov teebmeem:Cov tsos mob tshwm sim ntawm ob hom kev sib xyaw no tuaj yeem sib txawv heev vim lawv cov txheej txheem sib txawv thiab cov hom phiaj.
Kev kho muaj peev xwm ntawm Linaclotide
To taub qhov ntawdLinaclotidetsis yog prostaglandin derivative tab sis ib qho tshwj xeeb GC-C agonist pab kom txaus siab rau nws cov peev xwm kho mob tshwj xeeb. Linaclotide tau pom cov lus cog tseg tseem ceeb hauv kev kho mob cem quav thiab IBS-C, cov xwm txheej uas cuam tshuam rau ntau lab tus tib neeg thoob ntiaj teb.
Kev ua tau zoo ntawm Linaclotide hauv kev kho cov mob no tshwm sim los ntawm nws lub peev xwm los:
 |
 |
 |
Ua kom lub plab hnyuv tso tawm
Los ntawm activating GC-C receptors, Linaclotide txhawb kev tso tawm ntawm chloride thiab bicarbonate rau hauv plab hnyuv lumen, uas nqus dej rau hauv lub plab, ua kom cov quav thiab ua kom yooj yim.
01
Accelerate plab hnyuv Transit
Cov kua dej ntau ntxiv hauv cov hnyuv, ua ke nrog lwm cov teebmeem ntawm GC-C ua kom muaj zog, pab txhawb kev txav ntawm cov hnyuv, txo cov cem quav.
02
Txo qhov mob plab
Qee cov kev tshawb fawb qhia tias Linaclotide tuaj yeem ua rau muaj kev ua xua, uas tuaj yeem txo qis qhov mob ntawm cov hlab ntsha hauv cov hnyuv.
03
Tsawg kawg Systemic Absorption
Linaclotide ua haujlwm nyob rau hauv lub plab thiab yog me ntsis absorbed rau hauv cov hlab ntsha, uas tuaj yeem txo qhov kev pheej hmoo ntawm kev mob tshwm sim.
04
Kev sim tshuaj kho mob tau pom tias muaj txiaj ntsig zoo ntawm Linaclotide hauv kev txhim kho lub plab zom mov ntau zaus, quav quav, thiab cov tsos mob plab hauv cov neeg mob cem quav thiab IBS-C. Qhov no tau ua rau nws pom zoo los ntawm cov koom haum tswj hwm xws li FDA rau kev kho mob ntawm cov xwm txheej no.
Nws tsim nyog sau cia tias thaum Linaclotide tau ua pov thawj zoo rau ntau tus neeg mob, nws yuav tsis haum rau txhua tus. Ib yam li txhua yam tshuaj, nws yog ib qho tseem ceeb uas yuav tau sab laj nrog tus kws kho mob los txiav txim seb Linaclotide yog ib qho kev kho mob uas tsim nyog raws li tus neeg mob thiab cov kev xav tau.
Conclusion
Hauv kev xaus, thaumLinaclotidetsis yog prostaglandin derivative, nws sawv cev rau kev nce qib tseem ceeb hauv kev kho mob plab hnyuv. Nws cov txheej txheem tshwj xeeb ntawm kev ua raws li GC-C agonist muaj lub hom phiaj los tswj kev cem quav thiab IBS-C, muab kev pab rau ntau tus neeg mob uas yuav tsis tau teb zoo rau lwm yam kev kho mob. Raws li kev tshawb fawb txuas ntxiv mus, peb yuav pom ntau daim ntawv thov thiab cov txiaj ntsig ntawm cov tshuaj tshiab no hauv kev ua zaub mov noj.
Yog tias koj xav kawm ntxiv txog cov khoom siv tshuaj lossis cov txheej txheem uas ua rau lawv, nco ntsoov tias koj tuaj yeem tiv tauj nrog cov kws tshaj lij hauv kev ua haujlwm. Nrog rau lawv txoj kev koom tes ntau hauv kev tsim tshuaj thiab ua raws li cov qauv GMP thoob ntiaj teb, cov koom haum xws li Shaanxi Sprout TECH Co., Ltd. tuaj yeem muab cov ntaub ntawv tseem ceeb. Yog xav paub ntxiv, koj tuaj yeem hu rau lawv ntawmSales@bloomtechz.com.
Cov ntaub ntawv
Chey, WD, Lembo, AJ, & Lavins, BJ (2012). Linaclotide rau kev chim siab plob tsis so tswj nrog cem quav: ib 26-lub lim tiam, randomized, ob-dig muag, placebo-tswj sim los ntsuas kev ua tau zoo thiab kev nyab xeeb. American Journal of Gastroenterology, 107(11), 1702-1712.
Busby, RW, Bryant, AP, Bartolini, WP, Cordero, EA, Hannig, G., Kessler, MM, ... & Currie, MG (2010). Linaclotide, los ntawm kev ua kom muaj zog ntawm guanylate cyclase C, ua haujlwm hauv zos hauv plab hnyuv kom tshem tawm cov hnyuv ua kom zoo dua qub thiab hloov mus. European Journal of Pharmacology, 649({2}}), 328-335.
Blackshaw, LA, & Brierley, SM (2013). Emerging receptor target nyob rau hauv lub pharmacotherapy ntawm chim siab plob tsis so tswj syndrome nrog cem quav. Kws tshuaj ntsuam xyuas ntawm Gastroenterology & Hepatology, 7(sup1), 15-19.
Ricciotti, E., & FitzGerald, GA (2011). Prostaglandins thiab o. Arteriosclerosis, Thrombosis, thiab Vascular Biology, 31(5), 986-1000.
Lacy, BE, Levenick, JM, & Crowell, M. (2012). Kev cem quav ntev: kev kuaj mob tshiab thiab kev kho mob. Kev kho mob ua ntej hauv Gastroenterology, 5(4), 233-247.